National trends in screening, prevalence, and treatment of cardiovascular risk factors

被引:15
作者
Natarajan, S
Nietert, PJ
机构
[1] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA
[2] Med Univ S Carolina, Ctr Hlth Care Res, Charleston, SC 29425 USA
[3] Med Univ S Carolina, Div Gen Internal Med, Charleston, SC 29425 USA
关键词
hypertension; hypercholesterolemia; smoking; trends; population survey;
D O I
10.1016/S0091-7435(02)00057-9
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. Few studies have documented national trends in screening, awareness, and treatment of cardiovascular risk factors. We evaluated trends in screening, prevalence, and treatment of hypertension, hypercholesterolemia, and smoking. Methods. Data were analyzed from the 1984-1998 Behavioral Risk Factor Surveillance System, a series of yearly cross-sectional population-based surveys of U.S. adults. Unadjusted and adjusted time trends (age-, gender-, ethnicity-, education-, and income-adjusted) in screening, prevalence, and treatment were evaluated. Results. From 1984 to 1998, a larger proportion of U.S. adults were older, more educated, richer, and Hispanic. Hypertension screening was >97% (1988-1998), prevalence ranged from 21 to 24% (1984-1998), and approximately 58% (1984-1992) were prescribed blood-pressure-lowering medications. Hypercholesterolemia screening increased from 47 to 67% (1987-1998), prevalence from 18 to 31% (1987-1998), and cholesterol-lowering prescriptions from 22 to 25% (1988-1990). Smoking prevalence remained around 28% (19841998), while quit attempts declined from 63 to 47% (1990-1998). Conclusions. Although screening for hypertension and hypercholesterolemia has increased, a substantial proportion of cases were not being prescribed medications. While the prevalence of smoking remains constant, quit attempts have fallen. Continuing challenges for cardiovascular disease prevention include identification of individuals with hypercholesterolemia, appropriate prescription (initiation and/or maintenance) of antihypertensive and lipid-lowering medications, and intensifying smoking cessation efforts. (C) 2003 American Health Foundation and Elsevier Science (USA). All rights reserved.
引用
收藏
页码:389 / 397
页数:9
相关论文
共 42 条
[1]  
*AM HEART ASS, 1998, HEART STROK STAT
[2]  
[Anonymous], 1988, ARCH INTERN MED, V148, P1023
[3]   Trends in cigarette smoking: The Minnesota Heart Survey, 1980 through 1992 [J].
Arnett, DK ;
Sprafka, JM ;
McGovern, PG ;
Jacobs, DR ;
Shahar, E ;
McCarty, M ;
Luepker, RV .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1998, 88 (08) :1230-1233
[4]   Trends in hypertension prevalence, treatment, and control - In a well-defined older population [J].
Barker, WH ;
Mullooly, JP ;
Linton, KLP .
HYPERTENSION, 1998, 31 (01) :552-559
[5]   Seven year trends in plasma low-density-lipoprotein-cholesterol in young adults: The CARDIA study [J].
Bild, DE ;
Jacobs, DR ;
Liu, K ;
Williams, OD ;
Hilner, JE ;
Perkins, LL ;
Marcovina, SM ;
Hulley, SB .
ANNALS OF EPIDEMIOLOGY, 1996, 6 (03) :235-245
[6]   Shattuck lecture - Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities [J].
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (19) :1360-1369
[7]   TRENDS IN THE PREVALENCE, AWARENESS, TREATMENT, AND CONTROL OF HYPERTENSION IN THE ADULT US POPULATION - DATA FROM THE HEALTH EXAMINATION SURVEYS, 1960 TO 1991 [J].
BURT, VL ;
CUTLER, JA ;
HIGGINS, M ;
HORAN, MJ ;
LABARTHE, D ;
WHELTON, P ;
BROWN, C ;
ROCCELLA, EJ .
HYPERTENSION, 1995, 26 (01) :60-69
[8]   ROLE OF PRECLINICAL CARDIOVASCULAR-DISEASE IN THE EVOLUTION FROM RISK FACTOR EXPOSURE TO DEVELOPMENT OF MORBID EVENTS [J].
DEVEREUX, RB ;
ALDERMAN, MH .
CIRCULATION, 1993, 88 (04) :1444-1455
[10]  
ESCOBEDO LG, 1989, PUBLIC HEALTH REP, V104, P583